| Period Ending | Aug 2, 2013 | May 3, 2013 | Feb 1, 2013 | Nov 2, 2012 |
|---|
|
Total Revenue
|
14,514,000
|
14,074,000
|
14,314,000
|
13,721,000
| | Cost of Revenue | 11,825,000 | 11,327,000 | 11,205,000 | 10,849,000 | | |
Gross Profit
|
2,689,000
|
2,747,000
|
3,109,000
|
2,872,000
| |
|
Operating Expenses |
|
Research Development | 320,000 | 313,000 | 307,000 | 270,000 |
|
Selling General and Administrative | 2,097,000 | 2,208,000 | 2,104,000 | 2,013,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
272,000
|
226,000
|
698,000
|
589,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 151,000 | 226,000 | 698,000 | 684,000 |
|
Interest Expense | (68,000) | 68,000 | 38,000 | 133,000 |
|
Income Before Tax | 219,000 | 158,000 | 660,000 | 551,000 |
|
Income Tax Expense | 15,000 | 28,000 | 130,000 | 76,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 204,000 | 130,000 | 530,000 | 475,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
204,000
|
130,000
|
530,000
|
475,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
204,000
|
130,000
|
530,000
|
475,000
|
|
0.41%